Co-Authors
This is a "connection" page, showing publications co-authored by Fumihiro Ogawa and Kohei Takahashi.
Connection Strength
0.355
-
Temporal change in Syndecan-1 as a therapeutic target and a biomarker for the severity classification of COVID-19. Thromb J. 2021 Aug 16; 19(1):55.
Score: 0.241
-
Combining IL-6 and SARS-CoV-2 RNAaemia-based risk stratification for fatal outcomes of COVID-19. PLoS One. 2021; 16(8):e0256022.
Score: 0.060
-
Veno-venous extracorporeal membrane oxygenation for severe pneumonia: COVID-19 case in Japan. Acute Med Surg. 2020 Jan-Dec; 7(1):e509.
Score: 0.055